missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18561205

CCR9 Antibody (112509), DyLight 650, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB179W

Product Code. 18561205

  • € 711.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CCR9 Monoclonal antibody specifically detects CCR9 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CCR9
Monoclonal
DyLight 650
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF
112509
Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF-ready
C-C chemokine receptor type 9, C-C CKR-9, CC-CKR-9, CCR-9, CDw199, CDw199 antigen, chemokine (C-C motif) receptor 9, G protein-coupled receptor 28, GPR28, GPR-9-6G-protein coupled receptor 28
BaF3 mouse pro-B cell line transfected with human CCR9, Met1-Leu369, Accession # P51686
0.1 mL
Chemokines and Cytokines, Cytokine Research, GPCR, Immunology, Innate Immunity, Signal Transduction
10803
Store at 4°C in the dark.
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.